MedPage Today on MSN
Home-Based Neuromodulator Shows Promise for Suppressing Ventricular Arrhythmias
Feasibility of portable stellate ganglion phototherapy device shown in retrospective analy ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Ablation soon after first implantable cardioverter defibrillator shock for ventricular tachycardia ...
“Defibrillation testing can be safely omitted after S-ICD implantation when guided by the PRAETORIAN score,” Knops concluded, ...
Please provide your email address to receive an email when new articles are posted on . A single burst of antitachycardia pacing (ATP) reduced risk for shocks in patients with an implantable ...
The PRAETORIAN score is a noninvasive test that gives a score from 30 to 900, which can be interpreted as low risk (<90 ...
In the single-arm FULCRUM-VT trial, 59% of patients remained free of recurrent VT at 6 months, with less amiodarone use.
When implanting a subcutaneous ICD, routine defibrillation testing could be safely skipped when using a scoring system to ...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation ...
Medtronic (NYSE:MDT) today announced new clinical findings supporting its Aurora EV-ICD system and OmniaSecure defibrillation ...
Combined data from five implantable cardioverter-defibrillator (ICD) trials suggest that it is the underlying arrhythmic disorder, rather than the ICD therapy itself, that affects mortality in these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results